Close Menu

NEW YORK (GenomeWeb) – The US Food and Drug Administration today issued a revised guidance recommending universal testing of donated whole blood and blood components for Zika virus in the US and its territories.

The FDA first issued guidance on Feb. 16 recommending that only areas with active Zika virus transmission screen whole blood and blood components for the virus, use pathogen-reduction devices, or halt blood collection and obtain whole blood and blood components from areas of the US without active virus transmission.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.